BAKER BROS. ADVISORS LP – Reata Pharmaceuticals, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$5.62M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
-17.31%
quarter
Reata Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -1.17M | $25.13 | 223.97K | |
| Q2 2022 | share | 0.00% | 0 shares | -530K | $30.39 | 223.97K | |
| Q1 2022 | share | 0.00% | 0 shares | 1.43M | $32.76 | 223.97K | |
| Q4 2021 | share | 0.00% | 0 shares | -16.62M | $26.38 | 223.97K | |
| Q3 2021 | share | 0.00% | 0 shares | -9.16M | $100.61 | 223.97K | |
| Q2 2021 | share | 0.00% | 0 shares | 9.36M | $141.53 | 223.97K | |
| Q1 2021 | share | 0.00% | 0 shares | -5.35M | $99.7 | 223.97K | |
| Q4 2020 | share | Increase | +321.14% | 170.79K shares | 22.50M | $123.62 | 223.97K |
| Q3 2020 | share | Decrease | -5.00% | -2.8K shares | -3.55M | $97.42 | 53.18K |
| Q2 2020 | share | 0.00% | 0 shares | 653K | $156.02 | 55.98K | |
| Q1 2020 | share | Increase | +36.60% | 15K shares | -297K | $144.34 | 55.98K |
| Q4 2019 | share | Increase | 0.00% | 40.98K shares | 8.37M | $204.43 | 40.98K |